Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer

por Howard, David, James, David, Garcia-Parra, Jezabel, Pan-Castillo, Belen, Worthington, Jenny, Williams, Nicole, Coombes, Zoe, Rees, Sophie Colleen, Lutchman-Singh, Kerryn, Francis, Lewis W., Rees, Paul, Margarit, Lavinia, Conlan, R. Steven, Gonzalez, Deyarina
Publicado 2022